$CHKP

Chelouche Yoav sold $3.5M of CHKP

Chelouche Yoav sold 25,000 shares of CHECK POINT SOFTWARE TECHNOLOGIES LTD (CHKP) at $140.28 ($3.51M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Chelouche Yoav
Published Jun 4, 2026, 11:12 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CHKP
Neutral
medium confidence
Mentioned
$CHKP
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHKPNeutralLow
01

Why it matters

The disclosed sale can slightly weigh on short-term sentiment, but 10b5-1 scheduling typically limits the informational content versus unscheduled selling.

02

Market read

Traders may note the insider sale for sentiment/positioning, but there is no fundamental catalyst in the filing itself.

03

What to watch

The filing does not state whether other insiders or large holders changed positions around the same time; without that context, single-sale impact is likely overstated.

Relevance 6/10Novelty 6/10Timing: Filed today; sale executed on 2026-06-02 and disclosed 2026-06-04.

Background

SEC Form 4 reports insider transactions (director/officer/10%+ owners). This sale was executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$CHKPNeutralMedium confidence
Context

Director Yoav Chelouche sold 25,000 shares in an open-market transaction, disclosed via SEC Form 4 with a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures or fundamental news.

Evidence & confidence

The filing is a routine Form 4 for a director sale; 10b5-1 plans are typically scheduled and not necessarily information-driven.

Market effects

Minimal; this is company-specific insider activity with no stated sector/regulatory catalyst.

None indicated; CHKP is US-listed and the disclosure is not tied to a regional event.

None indicated; no cross-border deal or regulatory action mentioned.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity/compensation mechanics rather than bearish information.

Key entities

  • CHECK POINT SOFTWARE TECHNOLOGIES LTD

    CHKP; director Yoav Chelouche sold 25,000 shares open-market under a 10b5-1 plan.

Related articles

$CHKPMedAI 9/10

Check Point (CHKP) Q2 2026 Earnings Call Transcript

Check Point (CHKP) reported Q2 2026 revenue of $674M, up 1% YoY, driven by 12% growth in subscription revenue to $333M, while product revenue fell 14%. Non-GAAP EPS was $2.55, up 8%. Deferred revenue rose to $2.025B. Q3 guidance: revenue $665M-$685M, non-GAAP EPS $2.43-$2.53. Management reaffirmed FY2026 outlook and expanded its $2B buyback.

$CHKPMed

Check Point SmartConsole Authentication Bypass Is Under Active Attack, and a PoC Is Now Public

Check Point said active attacks target a SmartConsole authentication bypass in its Security Management and Multi-Domain Management servers. The flaw, CVE-2026-16232 (CVSS 9.3), can let an unauthenticated attacker obtain full admin access to the management plane under specific configurations. Rapid7 published analysis and a public PoC; CISA added the CVE to its Known Exploited list.

$CHKPMedAI 8/10

Check Point Software Technologies Q2 Earnings Call Highlights

Check Point (NASDAQ:CHKP) reported Q2 deferred revenue up 7% to $2.025B and remaining performance obligation up 7% to $2.55B. Current RPO rose 4% to $1.6B. Gross profit was $588M with 87% gross margin. Q3 guidance: revenue $655M-$685M, non-GAAP EPS $2.43-$2.53, adj. FCF $235M-$265M. CEO announced an AI Network Firewall and said sales hiring targets 300 roles for 2027.

$CHKPMed

Mixed results disappoint Check Point’s investors

Check Point Software Technologies (Nasdaq: CHKP) reported Q2 revenue of $674 million, slightly below analysts’ expectations, up 1.3% year over year. Security subscriptions rose to $333 million, but products and licenses fell 14% to $113 million. GAAP net profit was $194 million; non-GAAP profit $264 million, EPS $2.55. Shares fell 6.87% premarket.

$MSFTMed

Microsoft rally offsets Fed jitters; Quanta, Huntington Ingalls gain By Investing.com

U.S. stock index futures rose as Microsoft rallied after a fiscal Q4 2026 earnings beat, with revenue of $90.01B (+18% YoY) and non-GAAP EPS of $4.74. Quanta Services and Huntington Ingalls also gained on better-than-expected results and contract updates. Meta fell after earnings; other movers included Check Point, Capricor, Align, Hyatt, Sirius XM, Trinity, and ImmunityBio.

$CHKPHighAI 9/10

Why is Check Point Software stock sliding today? By Investing.com

Investing.com reports Check Point Software (CHKP) shares fell about 8.1% in pre-open trading after Q2 2026 results missed Wall Street revenue expectations and the company reduced its full-year revenue guidance. Analysts expected roughly $675M revenue and about $2.45 EPS. JPMorgan and Raymond James downgraded the stock, and insiders sold about $9.6M of shares.